CSIMarket
 


Sanofi  (SNY)
Other Ticker:  
 


Sanofi's ROI from its fourth quarter of 2023 to the fourth quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Sanofi's ROI in the fourth quarter of 2023?
Sanofi achieved a return on average invested assets (ROI) of 7.13 % in its fourth quarter of 2023, which is below Sanofi's average return on investment, which stands at 7.84%.

ROI fell compared to the third quarter of 2023, despite the net income growth of % from the third quarter of 2023.

Within the Healthcare sector 77 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2023 from 0 to 749.

Definition and Formula of Return on Investment


Return On Investment (Dec 31 2023)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Investment Change -1.02 % -1.02 % -1.02 % -1.02 % -
Y / Y Net Income Change -35.93 % - - - -31.3 %
Investment (TTM) in Millions 85,355 85,355 85,355 85,355 86,232
Return On Investment (TTM) 7.13 % 11.1 % 11.08 % 11.05 % 11.02 %
SNY's Overall Ranking # 749 # 0 # 0 # 0 # 952
Seq. Investment Change 0 % 0 % 0 % -1.02 % 0 %
Seq. Net Income Change - - - - -
Net Income (TTM) in Millions 6,088 9,502 9,502 9,502 9,502




Return On Investment SNY's Ranking
Within: No.
Industry # 23
Sector # 78
Overall # 749

Return On Investment Statistics
High Average Low
13.03 %
7.84 %
3.06 %
(Dec 31 2020)   (Dec 31 2019)







Financial Statements
Sanofi's IV. Quarter Investments $ 85,355 Millions SNY's Balance sheet
Sanofi's IV. Quarter Income $ 6,088 Millions Quarterly SNY's Income Statement
SNY's Income by Division See SNY's Income by Division


SNY Annual Return On Investment (Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2020)
2020
(Dec 31 2019)
2019
(Dec 31 2018)
2018
Total Investments in Millions 85,355 86,232 106,158 103,718 100,129
Y / Y Investment Growth -1.02 % -18.77 % 2.35 % 3.58 % -
Net Income in Millions 6,088 9,502 13,832 3,177 4,939
Y / Y Net Income Growth -35.93 % -31.3 % 335.32 % -35.67 % -
Annual Return On Investment 7.13 % 11.02 % 13.03 % 3.06 % 4.93 %


Annual Roi Comment
In the fiscal year 2023 ROI decreased relative to the previous year to 7.13 %, due to deterioration of net income.

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
SNY's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Return On Investment for SNY's Competitors
Roi for Sanofi's Suppliers
Return On Investment for SNY's Customers

Other Ratios
SNY's Roa SNY's Inventory Turnover Ratio SNY's Growth Rates SNY's Dividend Statistics
SNY's Profitability Ratios SNY's Asset Turnover Ratio SNY's Dividend Growth
SNY's Roe SNY's Valuation Ratios SNY's Financial Strength Ratios SNY's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2023, within Healthcare Sector ROI
Catalyst Pharmaceuticals Inc   19.15 %
Zoetis Inc   18.93 %
West Pharmaceutical Services Inc   18.65 %
Protalix Biotherapeutics inc   18.12 %
Edwards Lifesciences Corporation  17.49 %
Exelixis Inc   17.29 %
Halozyme Therapeutics Inc   16.81 %
Astrazeneca Plc  16.41 %
United Therapeutics Corporation  15.77 %
Eli Lilly And Company  15.18 %
Alpha Pro Tech Ltd   15.16 %
Regeneron Pharmaceuticals Inc   14.46 %
Resmed Inc   14.24 %
Intuitive Surgical Inc   14.18 %
Shockwave Medical Inc   13.81 %
Utah Medical Products Inc  13.61 %
Ufp Technologies Inc   13.08 %
Orasure Technologies Inc  12.68 %
Progyny Inc   12.20 %
Pro dex Inc   12.04 %
Dexcom Inc   12.01 %
Organon and Co   11.96 %
Cadre Holdings Inc   11.72 %
Baxter International Inc   11.56 %
Incyte Corporation  11.52 %
Gilead Sciences Inc   11.46 %
Tactile Systems Technology Inc   11.45 %
Neurocrine Biosciences Inc   11.39 %
Hologic Inc  11.38 %
Hutchmed china Limited  11.36 %


Date modified: 2024-02-23T19:23:01+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com